MeiraGTx (NASDAQ: MGTX - Get Free Report) and aTyr Pharma (NASDAQ: ATYR - Get Free Report) are both

Goldman Sachs analyst Andrea Newkirk initiates coverage on MeiraGTx Holdings (NASDAQ:MGTX) with a

LONDON and NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vert

Ascendis Pharma A/S (NASDAQ: ASND - Get Free Report) and MeiraGTx (NASDAQ: MGTX - Get Free Report) a

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI0

GV101, a novel, highly selective ROCK2 inhibitor, yielded an 86.2% best overall response rate (bORR)

RBC Capital analyst Lisa Walter maintains MeiraGTx Holdings (NASDAQ:MGTX) with a Outperform and r

MeiraGTx Holdings PLC (MGTX) came out with quarterly earnings of $1.71 per share, beating the Zacks

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly earnings of $1.71 per share which beat the analyst c

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly sales of $321.434 million which beat the analyst con

Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 and reported positive three-year data f

Graviton received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administratio

LONDON and NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a verti

MeiraGTx Holdings plc is positioned potentially for significant upside with late-stage gene therapy

The mean of analysts' price targets for MeiraGTx (MGTX) points to a 128.1% upside in the stock. Whil

Stuart Naylor liquidated 27,659 shares for $409,000 on July 7, 2026, at a weighted average price of

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte

MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than avera

RBC Capital analyst Lisa Walter maintains MeiraGTx Holdings (NASDAQ:MGTX) with a Outperform and r

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates MeiraGTx Holdings (NASDAQ:MGTX) wit

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines comp

LONDON and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a verti

MeiraGTx is evolving into a late-stage, manufacturing-enabled genetic medicine company with multiple

MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

RBC Capital analyst Lisa Walter maintains MeiraGTx Holdings (NASDAQ:MGTX) with a Outperform and r

MeiraGTx Holdings plc (MGTX) Presents at Bank of America Global Healthcare Conference 2026 Transcrip

LONDON and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertic

MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.57 per share versus the Zacks Cons

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.57) per share which missed the analyst

Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 Reported positive three-year data from

Piper Sandler analyst Allison Bratzel maintains MeiraGTx Holdings (NASDAQ:MGTX) with a Overweight

RBC Capital analyst Lisa Walter maintains MeiraGTx Holdings (NASDAQ:MGTX) with a Outperform and r

MeiraGTx reacquires bota-vec from Johnson & Johnson, outlining regulatory plans, funding outlook

MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines comp

Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all

Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (

MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines comp

Evercore ISI Group analyst Gavin Clark-Gartner maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outp

Piper Sandler analyst Allison Bratzel maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Overweight an

B of A Securities analyst Geoff Meacham maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and rai

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly earnings of $0.19 per share which beat the analyst c

HC Wainwright & Co. analyst Mitchell S. Kapoor initiates coverage on MeiraGTx Hldgs (NASDAQ:M

RBC Capital analyst Lisa Walter maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and rais

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and mai

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.62) per share which missed the analyst

Piper Sandler analyst Allison Bratzel maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Overweight an

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and mai